Cite
HARVARD Citation
Tzaridis, T. et al. (2021). MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial. International journal of cancer. 148 (7), pp. 1695-1707. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tzaridis, T. et al. (2021). MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA‐09 trial. International journal of cancer. 148 (7), pp. 1695-1707. [Online].